<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05112289</url>
  </required_header>
  <id_info>
    <org_study_id>21-006203</org_study_id>
    <nct_id>NCT05112289</nct_id>
  </id_info>
  <brief_title>A Study to Evaluate White Matter Hyperintensities in Migraine</brief_title>
  <official_title>White Matter Hyperintensities in Migraine: A Multi-modal Imaging Project to Classify Disease Pathology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to better understand brain white matter hyperintensities&#xD;
      (WMH) in women with migraines&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 16, 2021</start_date>
  <completion_date type="Anticipated">August 16, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 16, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>WMH imaging disease parameters</measure>
    <time_frame>3 months</time_frame>
    <description>Radiological MRI assessment of WMH in migraine</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Migraine</condition>
  <condition>Small Vessel Ischemic Disease</condition>
  <condition>Multiple Sclerosis</condition>
  <arm_group>
    <arm_group_label>Migraine cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women with migraine and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Small vessel ischemic (SVI) disease cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women diagnosed with SVI disease and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multiple sclerosis (MS) cohort</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Women diagnosed with MS and presence of white matter hyperintensities (WMH) on clinical magnetic resonance imaging (MRI) will have brain neuroimaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Brain Neuroimaging</intervention_name>
    <description>Non-invasive magnetic resonance imaging sequences will investigate metabolic signatures unique to migraine WMH. Imaging data will be used for development of artificial intelligence (AI) algorithms to classify the cause of WMHs.</description>
    <arm_group_label>Migraine cohort</arm_group_label>
    <arm_group_label>Multiple sclerosis (MS) cohort</arm_group_label>
    <arm_group_label>Small vessel ischemic (SVI) disease cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria - Migraine (N=20):&#xD;
&#xD;
          -  Female only.&#xD;
&#xD;
          -  Ages 20-45 years.&#xD;
&#xD;
          -  Presence of WMH on MRI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of SVI and/or history of MS or other neurological disease other than migraine.&#xD;
&#xD;
          -  History of cancer or organ transplantation.&#xD;
&#xD;
          -  Contraindication to MRI.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  History of abnormal brain MRI other than WMH.&#xD;
&#xD;
          -  Subjects not willing to comply with the study procedures will be removed from the&#xD;
             study.&#xD;
&#xD;
        Inclusion Criteria - SVI disease (n=10):&#xD;
&#xD;
          -  Female only&#xD;
&#xD;
          -  Ages &gt; 60 years.&#xD;
&#xD;
          -  Presence of WMH on MRI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of migraine and/or history of MS or other neurological disease other than SVI.&#xD;
&#xD;
          -  History of cancer or organ transplantation.&#xD;
&#xD;
          -  History of abnormal brain MRI other than WMH.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  History of abnormal brain MRI other than WMH.&#xD;
&#xD;
          -  Subjects not willing to comply with the study procedures will be removed from the&#xD;
             study.&#xD;
&#xD;
        Inclusion Criteria - MS (n=10):&#xD;
&#xD;
          -  Female only.&#xD;
&#xD;
          -  Ages 20-45.&#xD;
&#xD;
          -  Presence of WMH on MRI.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  History of migraine and/or history of SVI or other neurological disease other than MS.&#xD;
&#xD;
          -  History of cancer or organ transplantation.&#xD;
&#xD;
          -  History of abnormal brain MRI other than WMH.&#xD;
&#xD;
          -  Pregnancy.&#xD;
&#xD;
          -  History of abnormal brain MRI other than WMH.&#xD;
&#xD;
          -  Subjects not willing to comply with the study procedures will be removed from the&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>59 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Catherine Chong, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic in Arizona</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85054</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicole Williams, M.A.B.S</last_name>
      <phone>480-342-3757</phone>
      <email>williams.nicole1@mayo.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 12, 2021</study_first_submitted>
  <study_first_submitted_qc>November 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2021</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Catherine (Cat) Chong</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Multiple Sclerosis</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

